Your browser doesn't support javascript.
loading
Self versus Nonself Discrimination by the Soluble Complement Regulators Factor H and FHL-1.
Dopler, Arthur; Guntau, Leonie; Harder, Markus J; Palmer, Annette; Höchsmann, Britta; Schrezenmeier, Hubert; Simmet, Thomas; Huber-Lang, Markus; Schmidt, Christoph Q.
Afiliación
  • Dopler A; Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, 89081 Ulm, Germany.
  • Guntau L; Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, 89081 Ulm, Germany.
  • Harder MJ; Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, 89081 Ulm, Germany.
  • Palmer A; Institute of Clinical and Experimental Trauma-Immunology, University Hospital, 89081 Ulm, Germany.
  • Höchsmann B; Institute of Transfusion Medicine, University of Ulm, 89081 Ulm, Germany; and.
  • Schrezenmeier H; Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service Baden-Wurttemberg-Hessen and University Hospital, 89081 Ulm, Germany.
  • Simmet T; Institute of Transfusion Medicine, University of Ulm, 89081 Ulm, Germany; and.
  • Huber-Lang M; Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service Baden-Wurttemberg-Hessen and University Hospital, 89081 Ulm, Germany.
  • Schmidt CQ; Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, 89081 Ulm, Germany.
J Immunol ; 202(7): 2082-2094, 2019 04 01.
Article en En | MEDLINE | ID: mdl-30745459
ABSTRACT
The plasma proteins Factor H (FH) and its alternate splice variant FH-like protein 1 (FHL-1) are the major regulators of the complement alternative pathway. The indiscriminate nature of alternative pathway activation necessitates the regulators to be host selective, but the underlying principles of selectivity remained largely elusive. By analyzing human FH and FHL-1 for protection of different host and foreign cells (rabbit and yeast), we uncovered a 2-fold discriminatory mechanism of FH in favor of self relative to FHL-1, FH exhibits a regulatory benefit on self but importantly, also, a regulatory penalty on nonself surfaces, yielding a selectivity factor of ∼2.4 for sialylated host surfaces. We further show that FHL-1 possesses higher regulatory activity than known but is relatively unselective. The reason for this unexpected high activity of FHL-1 is the observation that the complement regulatory site in FH exceeds the established first four domains. Affinity for C3b, cofactor and decay-accelerating activities, and serum assays demonstrate that the regulatory site extends domains 1-4 and includes domains 5-7. But unlike FH, FHL-1 exhibits a fast plasma clearance in mice, occurs sparsely in human plasma (at one fortieth of the FH concentration), and resists deregulation by FH-related proteins. These physiological differences and its late phylogenetic occurrence argue that FHL-1 is crucial for local rather than systemic compartments. In conclusion, we demonstrate a 2-fold discriminatory power of FH to promote selectivity for self over foreign and show that FHL-1 is more active than known but specialized for regulation on local tissues.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Autotolerancia / Vía Alternativa del Complemento Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Immunol Año: 2019 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Autotolerancia / Vía Alternativa del Complemento Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Immunol Año: 2019 Tipo del documento: Article País de afiliación: Alemania